You are here
Clinical Trials: Liver Disease
Discuss
Each Clinical Trial will open in a new browser window or tab.
Condition: Acute-On-Chronic Liver Failure
Intervention: Biological: allo-APZ2-ACLF
Sponsors: RHEACELL GmbH & Co. KG; FGK Clinical Research GmbH; Ticeba GmbH
Not yet recruiting
Intervention: Biological: allo-APZ2-ACLF
Sponsors: RHEACELL GmbH & Co. KG; FGK Clinical Research GmbH; Ticeba GmbH
Not yet recruiting
Condition: Hepatitis B
Intervention: Biological: Peripheral iv
Sponsor: Sclnow Biotechnology Co., Ltd.
Recruiting
Intervention: Biological: Peripheral iv
Sponsor: Sclnow Biotechnology Co., Ltd.
Recruiting
Condition: Alcoholic Hepatitis
Intervention: Drug: GCSF
Sponsor: Postgraduate Institute of Medical Education and Research
Recruiting
Intervention: Drug: GCSF
Sponsor: Postgraduate Institute of Medical Education and Research
Recruiting
Condition: Primary Biliary Cirrhosis
Intervention: Procedure: mesenchymal stem cell transplantation or placebo infusion via peripheral vein
Sponsor: Xijing Hospital of Digestive Diseases
Recruiting
Intervention: Procedure: mesenchymal stem cell transplantation or placebo infusion via peripheral vein
Sponsor: Xijing Hospital of Digestive Diseases
Recruiting
Condition: Acute-On-Chronic Liver Failure
Intervention: Procedure: mesenchymal stem cell transplantation or placebo infusion via peripheral vein
Sponsor: Xijing Hospital of Digestive Diseases
Recruiting
Intervention: Procedure: mesenchymal stem cell transplantation or placebo infusion via peripheral vein
Sponsor: Xijing Hospital of Digestive Diseases
Recruiting
Condition: Decompensated Liver Cirrhosis
Intervention: Biological: UC-MSC
Sponsors: Shandong Qilu Stem Cells Engineering Co., Ltd.; Shanghai Public Health Clinical Center; First Affiliated Hospital of Fujian Medical University; Yantai Hospital for Infectious Diseases; The Second Affiliated Hospital of Chongqing Medical University; Jinan Hospital for Infectious Diseases
Not yet recruiting
Intervention: Biological: UC-MSC
Sponsors: Shandong Qilu Stem Cells Engineering Co., Ltd.; Shanghai Public Health Clinical Center; First Affiliated Hospital of Fujian Medical University; Yantai Hospital for Infectious Diseases; The Second Affiliated Hospital of Chongqing Medical University; Jinan Hospital for Infectious Diseases
Not yet recruiting
Condition: Liver Cirrhosis
Intervention: Biological: MSC
Sponsor: Nanjing Medical University
Not yet recruiting
Intervention: Biological: MSC
Sponsor: Nanjing Medical University
Not yet recruiting
Condition: Decompensated Liver Cirrhosis
Intervention: Biological: Mesenchymal stem cell
Sponsor: Rohto Pharmaceutical Co., Ltd.
Recruiting - verified August 2017
Intervention: Biological: Mesenchymal stem cell
Sponsor: Rohto Pharmaceutical Co., Ltd.
Recruiting - verified August 2017
Condition: Liver Cirrhosis
Interventions: Procedure: mesenchymal stem cell transplantation via peripheral vein; Other: mesenchymal stem cell
Sponsor: Xijing Hospital of Digestive Diseases
Recruiting - verified July 2017
Interventions: Procedure: mesenchymal stem cell transplantation via peripheral vein; Other: mesenchymal stem cell
Sponsor: Xijing Hospital of Digestive Diseases
Recruiting - verified July 2017
Condition: End Stage Liver Disease
Interventions: Drug: Neupogen; Procedure: CD133 Cells Transplantation
Sponsors: National University Hospital, Singapore; Singapore General Hospital; Tan Tock Seng Hospital; Changi General Hospital Singapore
Recruiting - verified February 2017
Interventions: Drug: Neupogen; Procedure: CD133 Cells Transplantation
Sponsors: National University Hospital, Singapore; Singapore General Hospital; Tan Tock Seng Hospital; Changi General Hospital Singapore
Recruiting - verified February 2017
